Elucidation of renal function protection with human atrial natriuretic peptide (hANP)

Elucidation of renal function protection with human atrial natriuretic peptide (hANP) - Elucidation of renal function protection with hANP

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000010970

Enrollment

Registered

2013-06-14

Start date

2009-12-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ischemic heart disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients of selective off pump coronary artery bypass grafting

Exclusion criteria

Exclusion criteria: preoperative renal disfunction , not heart failure

Design outcomes

Primary

Measure	Time frame
Urine epidermal growth factor and serum Inflammatory cytokine. These are measured before operation until 7th day after operation.	—

Countries

Japan

Contacts

Public ContactMari Koizumi

Faculty of medicine,Kagawa university Department of anesthesiology

mkoi@med-kagawa-u.ac.jp087-898-5111

Outcome results